Our most advanced product candidate, SPY001, is designed to be a highly potent, selective, and half-life extended monoclonal antibody that binds to the α4β7 integrin.
TL1A
SPY002
PRECLINICAL
Our co-lead product candidate, SPY002, is designed to be a highly potent, selective, and half-life extended monoclonal antibody that binds to tumor necrosis factor-like ligand 1A (“TL1A”).
IL-23
SPY003
PRECLINICAL
Our co-lead product candidate, SPY003, is designed to be a highly potent, selective, and half-life extended monoclonal antibody that binds to the p19 subunit of interleukin-23 cytokine (“IL-23p19”).